₹978.40
₹-12.55 (-1.27%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹2,041 Cr
P/E
30.72
ROE
11.44%
ROCE
14.90%
About Windlas Biotech Ltd
Windlas Biotech engaged in manufacturing and trading of pharmaceutical products.
Founded
2001
CEO
Vivek Dhariwal
Employees
1,385
HQ
Gurgaon, India
About Windlas Biotech Ltd
Windlas Biotech engaged in manufacturing and trading of pharmaceutical products.
Founded:2001
CEO:Vivek Dhariwal
Employees:1,385
HQ:Gurgaon, India
Finished Products
1Sale of Products
₹2,231.25Cr2Export Sales
₹45.84Cr3Other Operating Revenues
₹12.44Cr4Sale of Services
₹4.62Cr5Export Incentives
₹0.67Cr6Scrap sales
₹0.11CrRaw Materials
1Raw Materials consumed
₹1,430.10CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,036
52W Low
₹697
Volume58.24K
Avg VolumeN/A
Beta0.75
Dividend Yield0.64%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
30.72x
Valuation
P/B Ratio
3.52x
Valuation
EPS
₹32.20
Valuation
Dividend Yield
0.64%
Valuation
ROE
11.44%
Profitability
ROCE
14.90%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.06x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
12.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.